Next Article in Journal
Antiviral Activity of Metabolites from Peruvian Plants against SARS-CoV-2: An In Silico Approach
Previous Article in Journal
Measurement of Antioxidant Capacity of Meat and Meat Products: Methods and Applications
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Analysis of Volatile Molecules Present in the Secretome of the Fungal Pathogen Candida glabrata

by
Juan Ernesto López-Ramos
1,
Elihú Bautista
2,
Guadalupe Gutiérrez-Escobedo
1,
Gabriela Mancilla-Montelongo
3,
Irene Castaño
1,
Marco Martín González-Chávez
4 and
Alejandro De Las Peñas
1,*
1
IPICYT, División de Biología Molecular, Instituto Potosino de Investigación Científica y Tecnológica, Camino a la Presa San José, #2055, Col. Lomas 4ª Sección, San Luis Potosí CP 78216, San Luis Potosí, Mexico
2
IPICYT, CONACYT-Consorcio de Investigación, Innovación y Desarrollo para las Zonas Áridas, Instituto Potosino de Investigación Científica y Tecnológica A. C, Camino a la Presa San José, #2055, Col. Lomas 4ª Sección, San Luis Potosí CP 78216, San Luis Potosí, Mexico
3
CONACYT, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Yucatán, Carretera Mérida-Xmatkuil Km 15.5 S/N, Mérida CP 97100, Yucatán, Mexico
4
Facultad de Ciencias Químicas, Av. Dr Manuel Nava 6, Zona Universitaria, Universidad Autónoma de San Luis Potosí, San Luis Potosí CP 78290, San Luis Potosí, Mexico
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(13), 3881; https://doi.org/10.3390/molecules26133881
Submission received: 28 May 2021 / Revised: 15 June 2021 / Accepted: 21 June 2021 / Published: 25 June 2021

Abstract

:
Candida albicans, Candida glabrata, Candida parapsilosis and Candida tropicalis are the four most common human fungal pathogens isolated that can cause superficial and invasive infections. It has been shown that specific metabolites present in the secretomes of these fungal pathogens are important for their virulence. C. glabrata is the second most common isolate world-wide and has an innate resistance to azoles, xenobiotics and oxidative stress that allows this fungal pathogen to evade the immune response and persist within the host. Here, we analyzed and compared the C. glabrata secretome with those of C. albicans, C. parapsilosis, C. tropicalis and the non-pathogenic yeast Saccharomyces cerevisiae. In C. glabrata, we identified a different number of metabolites depending on the growth media: 12 in synthetic complete media (SC), 27 in SC-glutamic acid and 23 in rich media (YPD). C. glabrata specific metabolites are 1-dodecene (0.09 ± 0.11%), 2,5-dimethylundecane (1.01 ± 0.19%), 3,7-dimethyldecane (0.14 ± 0.15%), and octadecane (0.4 ± 0.53%). The metabolites that are shared with C. albicans, C. glabrata, C. parapsilosis, C. tropicalis and S. cerevisiae are phenylethanol, which is synthesized from phenylalanine, and eicosane and nonanoic acid (identified as trimethylsilyl ester), which are synthesized from fatty acid metabolism. Phenylethanol is the most abundant metabolite in all fungi tested: 26.36 ± 17.42% (C. glabrata), 46.77 ± 15.58% (C. albicans), 49.76 ± 18.43% (C. tropicalis), 5.72 ± 0.66% (C. parapsilosis.) and 44.58 ± 27.91% (S. cerevisiae). The analysis of C. glabrata’s secretome will allow us to further our understanding of the possible role these metabolites could play in its virulence.

1. Introduction

Candida spp. are the main cause of fungal infections in immunocompromised patients. These fungal pathogens can cause superficial and invasive infections [1]. In the US, these infections are caused by Candida albicans (39%), Candida glabrata (28%), Candida parapsilosis (15%) and Candida tropicalis (9%) [2].
It has been shown that diverse microbial pathogens have signaling mechanisms within the cell population for intercellular communication, which helps to develop a successful infection [3]. The secreted molecules constitute the secretome of these microbial pathogens and have a direct effect on cells in the population and other competing microbes. Saccharomyces cerevisiae, a non-pathogenic yeast closely related phylogenetically to C. glabrata, secretes phenylethanol, tyrosol and tryptophol to the environment and this induces filamentation in other nearby cells [4]. The synthesis of these aromatic alcohols depends on Aro8, Aro9 and Aro10 [5]. In C. albicans, it has been shown that the secreted farnesol can induce resistance to oxidative stress [6]. Resistance to the oxidative stress response is an important virulence factor in C. albicans.
In the last decade, C. glabrata has emerged as the second cause of candidiasis [7] and has been associated with high mortality in immunocompromised patients [8]. C. glabrata must be able to detect extracellular signals in the environment such as nutrient availability, presence of xenobiotics or reactive oxygen species, in order to reprogram gene expression to respond and adapt to the new environment within the host. The C. glabrata secretome has not been fully described. However, it is conceivable that specific molecules present in the secretome could modulate C. glabrata virulence factors such as: (a) adherence to host cells [9], (b) biofilm formation [10,11], (c) resistance to xenobiotics [12,13], and (d) the oxidative stress response, which is mediated by enzymatic (catalase, superoxide dismutases, sulfiredoxin, peroxiredoxins) and non-enzymatic (glutathione) mechanisms [14,15].
Recently, C. glabrata secreted proteomes and the secreted metabolite profiles from clinical isolates of Candida spp. from different sites (blood, respiratory tract and vulvovaginal) have been reported. These analyses have been carried out by liquid chromatography-tandem mass spectrometry (LC-MS/MS), matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS) and nuclear magnetic resonance (NMR) [16,17]. Furthermore, the presence of small molecular weight volatile molecules has been described from the Candida auris and C. albicans secretome by gas chromatography-mass spectrometry (GC-MS). GC-MS has the advantage that it can provide a quantitative analysis of volatile compounds from biological samples [18].
Here, we identified by GC-MS small molecular weight volatile molecules from C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae secretomes. We made a comparative analysis and found that the main molecules shared by these yeasts are derived from fatty acid and aromatic alcohol metabolism. In addition, we identified 1-dodecene, 2,5-dimethylundecane, 3,7-dimethyldecane and octadecane as specific metabolites present in the secretome of C. glabrata.

2. Results

The C. glabrata secretome has not been fully described and the identity of theses metabolites could be important for its virulence. To identify the molecules present in the secretome of C. glabrata, C. albicans, C. tropicalis, C. parapsilosis and S. cerevisiae (all strains are described in Table 1, see Section 4), cells were grown in YPD (rich media, Cg, Ca, Ct, Cp and Sc), SC (Synthetic complete media, Cg) and SC + GluNa (Synthetic complete media with glutamic acid as nitrogen source, Cg) and extracts from the cell-free supernatant were obtained from each culture and analyzed by GC-MS (see Section 4). The metabolites were identified and classified in three groups based on their biosynthetic origin: alkanes and alkenes, aldehydes and fatty acids and aromatics and phenolics (Figure 1). To ensure that the molecules identified were specific for each strain, the metabolites present in the media without cells were subtracted from the cell-free supernatant. We identified metabolites present in the C. glabrata, C. parapsilosis, C. albicans, C. tropicalis, and S. cerevisiae secretome grown in YPD: 23 in C. glabrata, 12 in C. parapsilosis, 20 in C. albicans, 12 in C. tropicalis, and 20 in S. cerevisiae (Figure 2). In C. glabrata, 27 metabolites were identified in SC + GluNa and 12 in SC media (Figure 2). Four metabolites were present only in C. glabrata: 1-dodecene (0.09 ± 0.11%), 2,5-dimethylundecane (1.01 ± 0.19%), 3,7-dimethyldecane (0.4 ± 0.53%) and octadecane (0.14 ± 0.15%) (Figure 2) [18].
Metabolites were classified according to their structures into three groups: alkanes and alkenes, aldehydes and fatty acids and aromatics, phenolics and others (see Section 4).
To determine which metabolites are shared by C. glabrata, C. parapsilosis, C. albicans, C. tropicalis and S. cerevisiae, we constructed a Venn Diagram (Figure 3) [19]. There are three molecules that are present in all of these fungal microorganisms: phenylethanol (Cg: 26.36 ± 17.42%, Cp: 5.72 ± 0.66%, Ca: 46.77 ± 15.58%, Ct: 49.76 ± 18.43%, and Sc: 44.58 ± 27.91%), nonanoic acid (Cg: 0.06 ± 0.06%, Cp: 0.14 ± 0.15%, Ca: 0.28 ± 0.06%, Ct: 0.06 ± 0.08%, Sc: 0.06 ± 0.06%), and eicosane (Cg: 0.03 ± 0.01%, Cp: 0.07 ± 0.02%, Ca: 0.49 ± 0.2%, Ct: 0.07 ± 0.04%, Sc: 0.07 ± 0.01%). The most abundant molecule shared by these microorganisms is phenylethanol. Both nonanoic acid and eicosane are products of fatty acid metabolism (Figure 3).
C. glabrata and S. cerevisiae are closely related phylogenetically and are classified in the Saccharomycetina clade. In contrast, C. albicans, C. parapsilosis and C. tropicalis are grouped in the CTG clade and are distantly related to the Saccharomycetina clade. To further understand the relation between the metabolites identified in each fungal microorganism, we constructed a cluster analysis (CA) and a principal component analysis (PCA) based on the presence or absence of the metabolites identified for each secretome [17,20,21]. The CA analysis shows that the metabolites are clustered in two groups: (a) metabolites present in S. cerevisiae, C. albicans and C. glabrata, and (b) metabolites present in C. parapsilosis and C. tropicalis (Figure 4). C. glabrata and S. cerevisiae share the highest number of metabolites (16 metabolites). Interestingly, 16 metabolites are also shared between S. cerevisiae and C. albicans, where heptadecane, tetradecane lauric acid (identified as trimethylsilyl laurate) and tyrosol are unique in this group. These metabolites are different from those shared between S. cerevisiae and C. glabrata. Metabolites only shared between S. cerevisiae and C. glabrata are 1,3-di-tert-butylbenzene, benzoic acid (identified as benzoic acid trimethylsilyl ester), stearic acid (identified as silylated derivative), and tyrosol. Interestingly, C. glabrata and C. albicans share 15 metabolites. C. glabrata unique metabolites are 1-dodecene, 2,5-dimethylundecane, 3,7-dimethyldecane, octadecanal, and octadecane, and for C. albicans are 2,6,11-trimethyldodecane and 2,6-dimethylundecane (Figure 2). The PCA also evaluates the relationship between the metabolites identified in Candida spp. and S. cerevisiae secretomes. This analysis confirms that the metabolites identified in C. parapsilosis and C. tropicalis are different from those identified in C. albicans, C. glabrata and S. cerevisiae (Figure 5).
Identified metabolites were analyzed by PCA. The contribution of a variable to a given principal component is in percentage. PCA was done using the prcomp function in R and the bi-plot generated using the factoextra package (see Section 4).
Phenylethanol, tyrosol and tryptophol have been shown to induce morphological changes in S. cerevisiae. We looked for the presence of these aromatic alcohols in the C. glabrata secretome in YPD, SC, SC + GluNa media. Phenylethanol is highly abundant in all three media used and tyrosol is not present in SC media. Surprisingly, we did not find tryptophol in the C. glabrata secretome in any of the media used (Figure 6A). In C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae secretomes, phenylethanol is present however, tryptophol is only present in C. albicans, C. tropicalis and S. cerevisiae; and tyrosol is present in C. glabrata and S. cerevisiae (Figure 6B).

3. Discussion

Candida spp. infections can be superficial or invasive and can be life threatening [22]. In the past decade, there has been an increase in candidiasis and candidemia caused by C. albicans, C. glabrata, C. parapsilosis, C. tropicalis and most recently by C. auris. C. glabrata is the second most common Candida isolate in nosocomial infections caused by fungi [23,24,25]. C. glabrata has several virulence factors that allow for a successful infection. C. glabrata adheres to biotic and abiotic surfaces, is capable of forming biofilms, and is resistant to xenobiotics and oxidative stress. In order to understand the role of the secretome of C. glabrata in virulence, we characterized and analyzed the C. glabrata secretome by GC-MS and compared it with C. tropicalis, C. albicans, C. parapsilosis and S. cerevisiae secretomes [26]. The specific metabolites present in C. glabrata are: 1-dodecene (0.09 ± 0.11%), 2,5-dimethylundecane (1.01 ± 0.19%), 3,7-dimethyldecane (0.14 ± 0.15%) and octadecane (0.4 ± 0.53%) and phenylethanol, nonanoic acid and eicosane are shared in C. glabrata, C. tropicalis, C. parapsilosis, C. tropicalis, C. albicans and S. cerevisiae secretomes.
In S. cerevisiae, it has been shown that the aromatic alcohols phenylethanol (Phe), tyrosol (Tyr) and tryptophol (Tryp) present in their secretomes can induce filamentation [27,28]. The synthesis of Phe, Tyr and Tryp requires ScAro8 (aromatic aminotransferase (i)), ScAro9 (aromatic aminotransferase (ii)) and ScAro10 (phenylpyruvate decarboxylase), and in addition, these enzymes are involved in the biosynthesis of aromatic amino acids [4,29,30,31]. The expression of ScARO8, ScARO9 and ScARO10 is repressed by (NH4)2SO4, thus abrogating the biosynthesis of theses aromatic alcohols [27]. In C. glabrata, CgAro8, CgAro9 and CgAro10 may play a similar role in the synthesis of Phe and Tyr. The concentration of these aromatic alcohols is reduced in SC + (NH4)2SO4 compared to SC + GluNa media (Figure 2). Interestingly, both the concentrations of these aromatic alcohols and additional metabolites are reduced (Figure 2). It is possible that nitrogen catabolite repression controls the expression of several genes encoding enzymes for the biosynthesis of these metabolites [32]. We were expecting to find Tryp in the C. glabrata secretome; however, the absence of Tryp could be due to either the methodology we applied to extract the molecules from the secretomes or strain specific differences.
Nonanoic acid is a 9-carbon fatty acid that has been shown to be present in Trichoderma harzianum, an entomopathogenic fungus. This fatty acid inhibits spore formation in Moniliophthora roreri and in Crinipellis perniciosa, both plant pathogenic fungi and can also inhibit their mycelial growth, but only at high concentrations [33]. In addition, it has been shown that nonanoic acid has antifungal activity against the fungal pathogen Trichophyton mentagrophytes and has also been identified in C. glabrata [19,34].
Eicosane is a 20-carbon alkane. It is a ubiquitous compound present in bacteria, plants and animals. Eicosane has been identified as a component of leaf cuticle in Agave attenuate and Triticum aestivu [35]. It has also been shown to be present in Streptomyces cacaoi and in specific organs of mammals like heart, kidney and in bovine adipocytes [36,37,38]. In human fungal pathogens up to now, eicosane has not been described in Candida species. Here, we now show that eicosane is present in C. glabrata, C. tropicalis, C. parapsilosis, C. tropicalis, C. albicans, and S. cerevisiae.
The identification of these three molecules present in C. glabrata, C. tropicalis, C. parapsilosis, C. tropicalis and C. albicans and Saccharomyces cerevisiae secretomes will allow us to ask whether these metabolites can modulate virulence in these fungal pathogens: are they signaling molecules that regulate stress responses? Can they induce morphological changes, or do they modify global transcriptional expression?

4. Materials and Methods

4.1. Strains

Table 1. Strains used in this study.
Table 1. Strains used in this study.
Strains Source of Reference
C. glabrataBG14ura3Δ:Tn903 Neo R Ura-[39]
C. parapsilosisATCC-22019Clinical IsolateLab. collection
C. tropicalisATCC-750Clinical IsolateLab. collection
C. albicans Sc5314 ATCC MYA2876Clinical IsolateLab. collection
S. cerevisiae S288c ATCC 504208MATα SUC2 mal mel gal2 CUP1Lab. collection

4.2. Media and Growth Conditions

Cells from Candida glabrata, Candida albicans, Candida tropicalis, Candida parapsilosis, and Saccharomyces cerevisiae were grown at 30 °C in: rich (YPD) medium containing yeast extract at 10 g/L, peptone at 20 g/L and 2% dextrose. Synthetic complete (SC) medium contained yeast nitrogen base at 1.7 g/L, (NH4)2SO4 at 5 g/L, 0.6% casamino acids, 2% glucose, and when needed, was supplemented with uracil at 25 mg/L. SC-GluNa medium is SC medium but (NH4)2SO4 was replaced for L-glutamic acid monosodium salt as a nitrogen source (1 g/L). Cells were grown for 72 h at 30 °C in 125 mL in Corning culture flasks. Cell-free supernatants were collected by centrifugation at 1300× g and filtration using 25 mm filter paper (Whatman) and syringe filters 0.2 µm (Nalgene Thermo Scientific). Fresh medium without cells was used as control to evaluate the relative concentration of metabolites in the media.

4.3. Sample Preparation for GC-MS Analysis

Samples were non-derivatized and derivatized for the GC-MS analysis. For derivatized samples, the preparation prior to GC-MS analysis was performed according to Semreen [18] methodology as follows: 30 mL from cell-free supernatants were extracted three times with 90 mL of chloroform (Fisher Scientific, Santa Clara, CA, USA). The chloroform layer was dehydrated over anhydrous sodium sulphate (Fisher Scientific), filtered, and followed by evaporation using a rotatory evaporator (Buchi, Essen, Germany). The residue collected from each extract was dissolved in 500 μL of chloroform prior to GC-MS injection. In addition, 100 µL of the chloroform extract was derivatized by adding 50 μL of N-trimethylsilyl-N-methyl trifluoroacetamide and trimethylchlorosilane (MSTFA + 1% TMS) followed by incubation at 50 °C for 30 min prior to GC-MS injection.

4.4. GC-MS Spectrometry Analysis

The GC-MS analysis was performed using a 7890B Gas Chromatograph (G3440B) coupled to a 5977A (G7039A) mass detector (Agilent Technologies, Santa Clara, CA, USA) with a HP-5ms UI column (30 m long × 0.25 mm internal diameter × 0.25 µm film thickness). The stripping gas used was helium (99.9995% purity) with a flow rate of 0.78371 mL/min. The initial temperature of the column was 70 °C maintained for 10 min followed by an increase of 10 °C/min to reach 200 °C, which was held for 10 min. The injection volume and injection temperature were 0.2 µL and 280 °C using splitless mode. The mass spectrometer operated in electron compact mode with an energy of 70 eV. Both the ion source temperature and the interface temperature were 230 °C and 200 °C respectively. The data acquisition mode was Scan starting at 20 to 500 m/z. Data collection and analysis were performed using MSD Enhanced ChemStation Software (Agilent Technologies). Mass spectra were identified by comparing the measured fragmentation patterns with those found in the W10N11 library database.

4.5. Statistical Analysis

The relative quantity of each metabolite was represented as relative percentage calculated by considering the area under the peak obtained by GC-MS of each metabolite as a ratio with the total area of all other metabolites. Data represent the mean of the relative percentage of three biological repeats ± SD. Heatmap was generated with Excel (Microsoft Office 2019) according to the relative percentage data of each metabolite [18]. Venn diagrams were performed using an online tool (http://jvenn.toulouse.inra.fr/app/example.html accessed on 28 May 2021) [19]. For the cluster analysis (CA), R software was used, applying Euclidian distance [21]. The principal component analysis (PCA) was done using the prcomp function in R and the bi-plot generated using the factoextra package [17,20,21]. Relative percentage of aromatic alcohols was analyzed using a two-way ANOVA analysis and Tukey’s pos-hoc test (p < 0.05). GraphPad Prism 8 was used to perform the analysis.

5. Conclusions

For a successful infection, fungal pathogens once engulfed by phagocytic cells, need to respond and adapt to the new environment. Fungal pathogens must detect the new hostile environment and reprogram gene expression in order to activate new pathways to maintain cell wall integrity, respond to xenobiotics, nutritional deprivation and oxidative stress. These responses allow survival and persistence within the host. Secreted metabolites by fungal pathogens have been proposed to be important for virulence. Some metabolites can induce morphological changes like filamentation (Phe, Tyro, Tryp) or induced resistance to oxidative stress (farnesol) in neighboring cells. Here, we identified specific metabolites in C. glabrata, C. tropicalis, C. parapsilosis, C. tropicalis, C. albicans and S. cerevisiae secretomes. These metabolites are products of fatty acid biosynthesis (nonanoic acid and eicosane) and aromatic alcohols (Phe, Tyro, Tryp). It is important to evaluate the biosynthesis pathways of theses metabolites and whether they can modulate the expression of stress response pathways (cell wall integrity, nutritional deprivation and resistance to xenobiotics and oxidative stress) as virulence factors in these fungal pathogens.

Author Contributions

Conceptualization, A.D.L.P.; formal analysis, J.E.L.-R. and E.B.; investigation, A.D.L.P., I.C., M.M.G.-C., G.M.-M. and G.G.-E.; methodology, G.G.-E., M.M.G.-C. and J.E.L.-R.; project administration, A.D.L.P.; supervision, A.D.L.P. and I.C.; writing—original draft, J.E.L.-R. and E.B.; writing—review and editing, E.B., G.G.-E., I.C. and A.D.L.P. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by Consejo Nacional de Ciencia y Tecnología (CONACYT) grant No. A1-S-9550 to A.D.L.P.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank Lina Riego for kindly providing C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae strains. J.E.L.-R. (CVU 164976) and G.M.-M. (CVU 200359) were supported by postdoctoral fellowships from Consejo Nacional de Ciencia y Tecnología (CONACYT).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sardi, J.C.O.; Scorzoni, L.; Bernardi, T.; Fusco-Almeida, A.M.; Mendes Giannini, M.J.S. Candida Species: Current Epidemiology, Pathogenicity, Biofilm Formation, Natural Antifungal Products and New Therapeutic Options. J. Med. Microbiol. 2013, 62, 10–24. [Google Scholar] [CrossRef]
  2. Toda, M.; Williams, S.R.; Berkow, E.L.; Farley, M.M.; Harrison, L.H.; Bonner, L.; Marceaux, K.M.; Hollick, R.; Zhang, A.Y.; Schaffner, W.; et al. Population-Based Active Surveillance for Culture-Confirmed Candidemia—Four Sites, United States, 2012–2016. MMWR. Surveill. Summ. 2019, 68, 1–15. [Google Scholar] [CrossRef]
  3. Honigberg, S.M. Cell Signals, Cell Contacts, and the Organization of Yeast Communities. Eukaryot. Cell 2011, 10, 466–473. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Chen, H.; Fink, G.R. Feedback control of morphogenesis in fungi by aromatic alcohols. Genes Dev. 2006, 20, 1150–1161. [Google Scholar] [CrossRef] [Green Version]
  5. Yashiroda, Y.; Yoshida, M. Intraspecies Cell-Cell Communication in Yeast. FEMS Yeast Res. 2019, 19. [Google Scholar] [CrossRef]
  6. Deveau, A.; Piispanen, A.E.; Jackson, A.A.; Hogan, D.A. Farnesol Induces Hydrogen Peroxide Resistance in Candida Albicans Yeast by Inhibiting the Ras-Cyclic AMP Signaling Pathway. Eukaryot. Cell 2010, 9, 569–577. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Pappas, P.G.; Lionakis, M.S.; Arendrup, M.C.; Ostrosky-Zeichner, L.; Kullberg, B.J. Invasive Candidiasis. Nat. Rev. Dis. Prim. 2018, 4, 18026. [Google Scholar] [CrossRef]
  8. Baddley, J.W.; Patel, M.; Bhavnani, S.M.; Moser, S.A.; Andes, D.R. Association of Fluconazole Pharmacodynamics With Mortality in Patients With Candidemia. Antimicrob. Agents Chemother. 2008, 52, 3022–3028. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Castaño, I.; Cormack, B.; De Las Peñas, A. Virulence of the Opportunistic Pathogen Mushroom Candida glabrata. Rev. Latinoam. Microbiol. 2007, 48, 66–69. [Google Scholar]
  10. Rodrigues, C.F.; Rodrigues, M.E.; Silva, S.C.; Henriques, M. Candida Glabrata Biofilms: How Far Have We Come? J. Fungi 2017, 3, 11. [Google Scholar] [CrossRef] [Green Version]
  11. Riera, M.; Mogensen, E.; D’Enfert, C.; Janbon, G. New Regulators of Biofilm Development in Candida Glabrata. Res. Microbiol. 2012, 163, 297–307. [Google Scholar] [CrossRef]
  12. Kołaczkowska, A.; Kołaczkowski, M. Drug Resistance Mechanisms and Their Regulation in Non-Albicans Candidaspecies. J. Antimicrob. Chemother. 2016, 71, 1438–1450. [Google Scholar] [CrossRef] [Green Version]
  13. Bhattacharya, S.; Sae-Tia, S.; Fries, B.C. Candidiasis and Mechanisms of Antifungal Resistance. Antibiotics 2020, 9, 312. [Google Scholar] [CrossRef]
  14. Briones-Martin-Del-Campo, M.; Orta-Zavalza, E.; Juarez-Cepeda, J.; Gutierrez-Escobedo, G.; Cañas-Villamar, I.; Castaño, I.; Peñas, A.D.L. The Oxidative Stress Response of the Opportunistic Fungal Pathogen Candida Glabrata. Rev. Iberoam. Micol. 2014, 31, 67–71. [Google Scholar] [CrossRef]
  15. Gutiérrez-Escobedo, G.; Orta-Zavalza, E.; Castaño, I.; Peñas, A.D.L. Role of Glutathione in the Oxidative Stress Response in the Fungal Pathogen Candida Glabrata. Curr. Genet. 2013, 59, 91–106. [Google Scholar] [CrossRef] [PubMed]
  16. Rasheed, M.; Kumar, N.; Kaur, R. Global Secretome Characterization of the Pathogenic Yeast Candida Glabrata. J. Proteome Res. 2019, 19, 49–63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Oliver, J.C.; Laghi, L.; Parolin, C.; Foschi, C.; Marangoni, A.; Liberatore, A.; Dias, A.L.T.; Cricca, M.; Vitali, B. Metabolic Profiling of Candida Clinical Isolates of Different Species and Infection Sources. Sci. Rep. 2020, 10, 1–14. [Google Scholar] [CrossRef] [PubMed]
  18. Semreen, M.H.; Soliman, S.S.M.; Saeed, B.Q.; Alqarihi, A.; Uppuluri, P.; Ibrahim, A.S. Metabolic Profiling of Candida Auris, a Newly-Emerging Multi-Drug Resistant Candida Species, by GC-MS. Molecules 2019, 24, 399. [Google Scholar] [CrossRef] [Green Version]
  19. Costa, C.P.; Bezerra, A.R.; Almeida, A.; Rocha, S.M. Candida Species (Volatile) Metabotyping through Advanced Comprehensive Two-Dimensional Gas Chromatography. Microorganisms 2020, 8, 1911. [Google Scholar] [CrossRef]
  20. Škrbić, B.; Durisic-Mladenovic, N.; Cvejanov, J. Principal Component Analysis of Trace Elements in Serbian Wheat. J. Agric. Food Chem. 2005, 53, 2171–2175. [Google Scholar] [CrossRef]
  21. Škrbić, B.D.; Buljovčić, M.; Jovanović, G.; Antić, I. Seasonal, Spatial Variations and Risk Assessment of Heavy Elements in Street Dust from Novi Sad, Serbia. Chemosphere 2018, 205, 452–462. [Google Scholar] [CrossRef] [PubMed]
  22. Deorukhkar, S.C.; Saini, S.; Mathew, S. Non-Albicans CandidaInfection: An Emerging Threat. Interdiscip. Perspect. Infect. Dis. 2014, 2014, 1–7. [Google Scholar] [CrossRef] [Green Version]
  23. Vazquez, J.A.; Dembry, L.M.; Sanchez, V.; Vazquez, M.A.; Sobel, J.D.; Dmuchowski, C.; Zervos, M.J. Nosocomial Candida Glabrata Colonization: An Epidemiologic Study. J. Clin. Microbiol. 1998, 36, 421–426. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Ruan, S.-Y.; Lee, L.-N.; Jerng, J.-S.; Yu, C.-J.; Hsueh, P.-R. Candida Glabrata Fungaemia in Intensive Care Units. Clin. Microbiol. Infect. 2008, 14, 136–140. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Mashaly, G.; Shrief, R. Candida Glabrata Complex from Patients With Healthcare-Associated Infections in Mansoura University Hospitals, Egypt: Distribution, Antifungal Susceptibility and Effect of Fluconazole and Polymyxin B Combination. Germs 2019, 9, 125–132. [Google Scholar] [CrossRef] [PubMed]
  26. Marcet-Houben, M.; Gabaldón, T. The Tree Versus the Forest: The Fungal Tree of Life and the Topological Diversity Within the Yeast Phylome. PLoS ONE 2009, 4, e4357. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Ghosh, S.; Kebaara, B.W.; Atkin, A.L.; Nickerson, K.W. Regulation of Aromatic Alcohol Production in Candida Albicans. Appl. Environ. Microbiol. 2008, 74, 7211–7218. [Google Scholar] [CrossRef] [Green Version]
  28. Hazelwood, L.A.; Daran, J.-M.; van Maris, A.J.A.; Pronk, J.T.; Dickinson, J.R. The Ehrlich Pathway for Fusel Alcohol Production: A Century of Research on Saccharomyces Cerevisiae Metabolism. Appl. Environ. Microbiol. 2008, 74, 2259–2266. [Google Scholar] [CrossRef] [Green Version]
  29. Etschmann, M.M.W.; Bluemke, W.; Sell, D.; Schrader, J. Biotechnological production of 2-phenylethanol. Appl. Microbiol. Biotechnol. 2002, 59, 1–8. [Google Scholar] [CrossRef]
  30. Lingappa, B.T.; Prasad, M.; Lingappa, Y.; Hunt, D.F.; Biemann, K. Phenethyl Alcohol and Tryptophol: Autoantibiotics Produced by the Fungus Candida Albicans. Science 1969, 163, 192–194. [Google Scholar] [CrossRef]
  31. Martins, M.; Henriques, M.; Azeredo, J.; Rocha, S.M.; Coimbra, M.A.; Oliveira, R. Morphogenesis Control in Candida Albicans and Candida Dubliniensis through Signaling Molecules Produced by Planktonic and Biofilm Cells. Eukaryot. Cell 2007, 6, 2429–2436. [Google Scholar] [CrossRef] [Green Version]
  32. Los Santos, F.J.P.-D.; García-Ortega, L.F.; Robledo-Márquez, K.; Guzmán-Moreno, J.; Riego-Ruiz, J.G.-M.A.L. Transcriptome Analysis Unveils Gln3 Role in Amino Acids Assimilation and Fluconazole Resistance in Candida Glabrata. J. Microbiol. Biotechnol. 2021, 31, 659–666. [Google Scholar] [CrossRef] [PubMed]
  33. Aneja, M.; Gianfagna, T.J.; Hebbar, P.K. Trichoderma Harzianum Produces Nonanoic Acid, an Inhibitor of Spore Germination and Mycelial Growth of Two Cacao Pathogens. Physiol. Mol. Plant Pathol. 2005, 67, 304–307. [Google Scholar] [CrossRef]
  34. Jang, Y.-W.; Jung, J.-Y.; Lee, I.-K.; Kang, S.-Y.; Yun, B.-S. Nonanoic Acid, an Antifungal Compound from Hibiscus Syriacus Ggoma. Mycobiology 2012, 40, 145–146. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Lavergne, F.D.; Broeckling, C.D.; Cockrell, D.M.; Haley, S.D.; Peairs, F.B.; Jahn, C.E.; Heuberger, A.L. GC-MS Metabolomics to Evaluate the Composition of Plant Cuticular Waxes for Four Triticum Aestivum Cultivars. Int. J. Mol. Sci. 2018, 19, 249. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Nandhini, U.S.; Sangareshwari, S.; Lata, K. Gas chromatography-mass spectrometry analysis of bioactive constituents from the marine streptomyces. Asian J. Pharm. Clin. Res. 2015, 8, 244–246. [Google Scholar]
  37. Cain, C.E.; Bell, O.E.; White, H.B.; Sulya, L.L.; Smith, R.R. Hydrocarbons from Human Meninges and Meningiomas. Biochim. Biophys. Acta (BBA) Lipids Lipid Metab. 1967, 144, 493–500. [Google Scholar] [CrossRef]
  38. Lintas, C.; Balduzzi, A.M.; Bernardini, M.P.; Di Muccio, A. Distribution of Hydrocarbons in Bovine Tissues. Lipids 1979, 14, 298–303. [Google Scholar] [CrossRef]
  39. Cormack, B.P.; Falkow, S. Efficient homologous and illegitimate recombination in the opportunistic yeast pathogen Candida glabrata. Genetics 1999, 151, 979–987. [Google Scholar] [CrossRef]
Figure 1. C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae metabolites identified by GC-MS.
Figure 1. C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae metabolites identified by GC-MS.
Molecules 26 03881 g001
Figure 2. Heatmap of the main metabolites identified in C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae. (A) Average of relative percentage of metabolites identified by GC-MS without derivative treatment. (B) Average of relative percentage of metabolites identified by the derivatization process prior to GC-MS analysis. Numbers are the average of the relative percentage of a given metabolite of four experimental replicates from three independent biological experiments and are displayed as colors ranging from red (low) to green (high). The relative percentage of a metabolite is represented as a ratio to the total area of all detected metabolites. C. parapsilosis, C. albicans, C. tropicalis, S. cerevisiae metabolites were obtained from cells grown on YPD. C. glabrata metabolites were obtained from cells grown on YPD, SC and SC+GluNa (see Section 4). * Identified as silylated derivative.
Figure 2. Heatmap of the main metabolites identified in C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae. (A) Average of relative percentage of metabolites identified by GC-MS without derivative treatment. (B) Average of relative percentage of metabolites identified by the derivatization process prior to GC-MS analysis. Numbers are the average of the relative percentage of a given metabolite of four experimental replicates from three independent biological experiments and are displayed as colors ranging from red (low) to green (high). The relative percentage of a metabolite is represented as a ratio to the total area of all detected metabolites. C. parapsilosis, C. albicans, C. tropicalis, S. cerevisiae metabolites were obtained from cells grown on YPD. C. glabrata metabolites were obtained from cells grown on YPD, SC and SC+GluNa (see Section 4). * Identified as silylated derivative.
Molecules 26 03881 g002
Figure 3. Venn diagram analysis of shared and specific metabolites in C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae.
Figure 3. Venn diagram analysis of shared and specific metabolites in C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae.
Molecules 26 03881 g003
Figure 4. Cluster analysis (CA) of the main metabolites from C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae. The dendrogram depicts the relative distance between Candida strains and S. cerevisiae. Zero indicates complete similarity and 10 indicates minimal similarity (see Section 4).
Figure 4. Cluster analysis (CA) of the main metabolites from C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae. The dendrogram depicts the relative distance between Candida strains and S. cerevisiae. Zero indicates complete similarity and 10 indicates minimal similarity (see Section 4).
Molecules 26 03881 g004
Figure 5. Bi-plot of data from Principal Component Analysis (PCA) for metabolites identified in C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae (see Section 4).
Figure 5. Bi-plot of data from Principal Component Analysis (PCA) for metabolites identified in C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae (see Section 4).
Molecules 26 03881 g005
Figure 6. Aromatic alcohols present in the secretome of C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae. Samples were analyzed by GC-MS and relative percentage of phenylethanol, tryptophol and tyrosol are shown. (A) Relative percentage of aromatic alcohols in C. glabrata grown in YPD, SC and SC + GluNa. (B) Relative percentage of aromatic alcohols identified in C. albicans, C. parapsilosis, C. tropicalis, and S. cerevisiae grown in YPD. If a bar is not present, this indicates the absence of the aromatic alcohol. Data was analyzed using a two-way ANOVA analysis and Tukey’s pos-hoc test. * Indicates p < 0.05, *** Indicates p < 0.001, **** p < 0.0001 (see Section 4).
Figure 6. Aromatic alcohols present in the secretome of C. glabrata, C. albicans, C. parapsilosis, C. tropicalis and S. cerevisiae. Samples were analyzed by GC-MS and relative percentage of phenylethanol, tryptophol and tyrosol are shown. (A) Relative percentage of aromatic alcohols in C. glabrata grown in YPD, SC and SC + GluNa. (B) Relative percentage of aromatic alcohols identified in C. albicans, C. parapsilosis, C. tropicalis, and S. cerevisiae grown in YPD. If a bar is not present, this indicates the absence of the aromatic alcohol. Data was analyzed using a two-way ANOVA analysis and Tukey’s pos-hoc test. * Indicates p < 0.05, *** Indicates p < 0.001, **** p < 0.0001 (see Section 4).
Molecules 26 03881 g006
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

López-Ramos, J.E.; Bautista, E.; Gutiérrez-Escobedo, G.; Mancilla-Montelongo, G.; Castaño, I.; González-Chávez, M.M.; De Las Peñas, A. Analysis of Volatile Molecules Present in the Secretome of the Fungal Pathogen Candida glabrata. Molecules 2021, 26, 3881. https://doi.org/10.3390/molecules26133881

AMA Style

López-Ramos JE, Bautista E, Gutiérrez-Escobedo G, Mancilla-Montelongo G, Castaño I, González-Chávez MM, De Las Peñas A. Analysis of Volatile Molecules Present in the Secretome of the Fungal Pathogen Candida glabrata. Molecules. 2021; 26(13):3881. https://doi.org/10.3390/molecules26133881

Chicago/Turabian Style

López-Ramos, Juan Ernesto, Elihú Bautista, Guadalupe Gutiérrez-Escobedo, Gabriela Mancilla-Montelongo, Irene Castaño, Marco Martín González-Chávez, and Alejandro De Las Peñas. 2021. "Analysis of Volatile Molecules Present in the Secretome of the Fungal Pathogen Candida glabrata" Molecules 26, no. 13: 3881. https://doi.org/10.3390/molecules26133881

APA Style

López-Ramos, J. E., Bautista, E., Gutiérrez-Escobedo, G., Mancilla-Montelongo, G., Castaño, I., González-Chávez, M. M., & De Las Peñas, A. (2021). Analysis of Volatile Molecules Present in the Secretome of the Fungal Pathogen Candida glabrata. Molecules, 26(13), 3881. https://doi.org/10.3390/molecules26133881

Article Metrics

Back to TopTop